这家总部位于香港的公司成立于2003年，在截至2025年3月31日的12个月内录得营业收入2500万美元。 公司计划在纳斯达克上市，股票代码为"AED"。Maxim Group LLC是本交易的独家簿记行。 栢威医药通过其子公司，向香港及中国内地的分销商和医疗机构销售医疗设备及软件。其产品包括输液 泵、麻醉喉镜、便携式X光机、自动体外除颤仪等医疗产品，以及一套自主开发的医疗软件，包括临床 前影像后处理软件Prim和核磁共振分析软件iMRIPlus。 总部位于香港的医疗设备和软件采购商栢威医药(AED.US)于上周四向美国证券交易委员会(SEC)提交文 件，计划通过首次公开募股(IPO)筹集至多700万美元资金。该公司计划以每股7至9美元的价格发行90万 股股票，筹资700万美元。按拟议发行区间的中值计算，栢威医药的市值将达到8700万美元。 ...

Core Insights - Lumexa Imaging Holdings, Bluerock Acquisition, and Carbon Capital Partners collectively raised $913 million upon their NASDAQ debut on December 11 [1] - Lumexa Imaging Holdings opened at $18.65 per share, slightly above its offering price, and closed at $18.52, with a total market capitalization of $1.751 billion [1][4] - Lumexa Imaging reported revenues of $755 million and a net loss of $18.41 million for the nine months ending September 30, 2025 [4] New Listings - Lumexa Imaging Holdings (LMRI) raised $463 million by issuing 25 million shares at $18.50 each, with funds allocated for repaying existing loans and general corporate purposes [4] - Bluerock Acquisition (BLRKU) and Carbon Capital Partners (KBONU) also listed on the same day, raising $150 million and $300 million respectively [5] IPO Filings - Brand Meditech Limited, a Chinese company, filed for an IPO with plans to list on NASDAQ under the ticker AED, aiming to raise between $6.3 million and $8.1 million by offering 900,000 shares at $7 to $9 each [6][10] - Brand Meditech specializes in medical devices and software, including infusion pumps and portable X-ray machines, targeting various medical fields [10] Financial Data - For the fiscal years ending March 31, 2024, and 2025, Brand Meditech reported revenues of $2.619 million and $2.549 million, with net profits of $1.47 million and $1.21 million respectively [11]